Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

NCT01327235 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Pleural Effusion
Malignant Ascites

Interventions

DRUG: Endostar
DRUG: Cisplatin

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.